Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5859 USD | +6.51% | +34.07% | -73.25% |
Jun. 03 | Aethlon Medical, Inc. Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies | CI |
May. 15 | Top Midday Decliners | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 5.41M |
---|---|---|---|---|---|
Net income 2024 * | -13M | Net income 2025 * | -13M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.11
x | P/E ratio 2025 * |
-0.17
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.66% |
Latest transcript on Aethlon Medical, Inc.
1 day | +6.51% | ||
1 week | +34.07% | ||
Current month | +34.07% | ||
1 month | -54.23% | ||
3 months | -65.54% | ||
6 months | -71.97% | ||
Current year | -73.25% |
Managers | Title | Age | Since |
---|---|---|---|
James Frakes
CEO | Chief Executive Officer | 67 | 08-01-08 |
Lee Arnold
CTO | Chief Tech/Sci/R&D Officer | 64 | - |
Guy Cipriani
COO | Chief Operating Officer | 54 | 18-06-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Frakes
CEO | Chief Executive Officer | 67 | 08-01-08 |
Chairman | 88 | 99-03-09 | |
Guy Cipriani
COO | Chief Operating Officer | 54 | 18-06-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 0.5859 | +6.51% | 15,641,758 |
24-06-06 | 0.5501 | +25.42% | 95,686,675 |
24-06-05 | 0.4386 | +6.98% | 16,336,935 |
24-06-04 | 0.41 | -10.87% | 1,894,878 |
24-06-03 | 0.46 | +5.26% | 5,206,008 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-73.25% | 5.41M | |
+9.48% | 222B | |
+13.72% | 195B | |
+23.79% | 148B | |
+33.39% | 113B | |
+4.75% | 66.45B | |
+15.59% | 53.11B | |
+3.16% | 50.03B | |
-4.35% | 38.8B | |
-1.27% | 34.85B |
- Stock Market
- Equities
- AEMD Stock